Parallax Volatility Advisers’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-6,472
Closed -$3.27M 2163
2024
Q3
$3.27M Sell
6,472
-183
-3% -$88.9K 0.01% 960
2024
Q2
$3.24M Buy
6,655
+2,581
+63% +$1.3M 0.01% 862
2024
Q1
$2.2M Buy
+4,074
New +$2.23M ﹤0.01% 1004
2023
Q2
Sell
-707
Closed -$354K 2636
2023
Q1
$354K Buy
+707
New +$338K ﹤0.01% 1835
2022
Q2
Sell
-2,411
Closed -$983K 3058
2022
Q1
$1.32M Buy
2,411
+678
+39% +$357K ﹤0.01% 1533
2021
Q4
$1.14M Sell
1,733
-2,410
-58% -$1.51M ﹤0.01% 1848
2021
Q3
$2.58M Buy
4,143
+3,669
+774% +$2.47M ﹤0.01% 1550
2021
Q2
$299K Buy
474
+298
+169% +$165K ﹤0.01% 2348
2021
Q1
$86K Buy
176
+65
+59% +$32.6K ﹤0.01% 2869
2020
Q4
$55K Sell
111
-5,935
-98% -$2.66M ﹤0.01% 3045
2020
Q3
$2.38M Buy
6,046
+838
+16% +$310K ﹤0.01% 1619
2020
Q2
$1.72M Sell
5,208
-668
-11% -$193K ﹤0.01% 1531
2020
Q1
$1.42M Buy
5,876
+5,443
+1,257% +$1.42M ﹤0.01% 1358
2019
Q4
$113K Buy
+433
New +$114K ﹤0.01% 2113
2019
Q1
Sell
-1,593
Closed -$296K 3329
2018
Q4
$296K Buy
+1,593
New +$327K ﹤0.01% 1647
2018
Q1
Sell
-2,371
Closed -$371K 3167
2017
Q4
$371K Buy
+2,371
New +$373K ﹤0.01% 1752
2017
Q2
Sell
-1,821
Closed -$282K 3015
2017
Q1
$282K Buy
1,821
+301
+20% +$41.5K ﹤0.01% 1796
2016
Q4
$178K Buy
+1,520
New +$173K ﹤0.01% 1936
2015
Q3
Sell
-2,828
Closed -$203K 3423
2015
Q2
$181K Buy
+2,828
New +$196K ﹤0.01% 2031

Other funds holding IDXX

Parallax Volatility Advisers's IDXX Position: Q4 2024 in Review

Parallax Volatility Advisers sold out of Idexx Laboratories (IDXX) in Q4 2024, closing a stake of 6,472 shares — an estimated $3.27M sold.

Parallax Volatility Advisers first reported a position in IDXX in Q2 2015 and held it in 19 quarters. The position peaked at $3.27M in Q3 2024. 1,125 funds tracked by Wall St. Rank hold IDXX as of Q4 2024.

  • Parallax Volatility Advisers reported no remaining Idexx Laboratories position as of Q4 2024 after selling out during the quarter.
  • Parallax Volatility Advisers sold 6,472 Idexx Laboratories shares in Q4 2024, an estimated $3.27M.
  • Parallax Volatility Advisers first reported a position in Idexx Laboratories in Q2 2015 and held it in 19 quarters.
  • Parallax Volatility Advisers's Idexx Laboratories position peaked at $3.27M in Q3 2024.
  • 1,125 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2024.

Based on Parallax Volatility Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.